Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

AJMC

Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

By Elise S. Tremblay, MD, MPH
Stephanie Argetsinger, MS, MPH

July 31st 2025

Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.

PFAS | Image credit: Vodkaz - stock.adobe.com

PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds

By Pearl Steinzor

July 29th 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com

SGLT2i-Induced Erythrocytosis Not Linked to Clots in Type 2 Diabetes

By Pearl Steinzor

July 21st 2025

MRI head brain scan - DedMityay - stock.adobe.com

Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes

By Pearl Steinzor

July 18th 2025

Doctor examines eye anatomy model using magnifying glass | Image credit: Viktor - stock.adobe.com

Clinical Data Predicts Risk of Progression to Proliferative Diabetic Retinopathy

By Pearl Steinzor

July 15th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background

Continuing Medical Education

August 3rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

August 3rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

September 23rd 2015

Type 2 Diabetes Patients Should Be Screened for Liver Disease, Study Suggests

Mary K. Caffrey

Screening in a primary care setting may help managed care plans avoid long-term costs of complications of type 2 diabetes.

September 23rd 2015

Clinton Seeks Cap on Drug Expenses, Would Let Medicare Negotiate

Mary K. Caffrey

Hillary Clinton unveiled a plan in Iowa that features a $250 per month cap on drug costs for patients with chronic conditions. This comes 2 weeks after her chief rival for the Democratic nomination, US Senator Bernie Sanders of Vermont, introduced a bill aimed at reining in drug costs. In the summer, The American Journal of Managed Care said polling showed that rising drug costs were poised to become a major issue in the 2016 campaign.

September 23rd 2015

Physicians Believe in Biosimilars but Lack Awareness, Says Report by Quantia

Surabhi Dangi-Garimella, PhD

A white paper released by QuantiaMD has identified a lack of awareness and education about biosimilars among prescribing physicians.

September 22nd 2015

Intarcia Says Phase 3 Results Show Better Control Than Januvia for Type 2 Diabetes Mellitus

Mary K. Caffrey

The matchstick-like delivery system has been seen as game-changer in overcoming poor adherence. Filing for FDA approval is anticipated in early 2016.

September 22nd 2015

JAMA: High-Dose Liraglutide Causes Significant Weight Loss in Overweight Persons With T2DM

Mary K. Caffrey

The study showed an average weight loss of 6%, and weight loss of 10% for a quarter of the patients. Average BMI was 37.

September 22nd 2015

Research Describes "Dimmer Switch" in Pancreatic Islet Cells

The research could hold the key to a novel treatment for type 2 diabetes, although it will take years to adapt the idea to clinical practice.

September 21st 2015

Does Passive Smoking Boost Diabetes Risk? A Lancet Meta-analysis Says Yes

Mary K. Caffrey

Researcher found that not only was passive smoking associated with increased risk of type 2 diabete, but there was a direct dose-response relationship.

September 21st 2015

New FDA Nominee May Face Challenges for His Pharma Ties

Surabhi Dangi-Garimella, PhD

A report in The New York Times identifies challenges that could be raised based on Califf's past associations with the drug industry.

Dr Andrew Pumerantz Reflects on the Role of Primary Care in Diabetes

September 21st 2015

Dr Andrew Pumerantz Reflects on the Role of Primary Care in Diabetes

Although primary care is important, it may not be the center of the care model for patients with chronic diseases, like type 2 diabetes, and these providers are usually just a part of a larger ecosystem of providers, said Andrew Pumerantz, DO, FACP.

September 19th 2015

Integrating Community, Clinical Services to Prevent and Treat Obesity

Laura Joszt, MA

Researchers are proposing a new model to integrate clinical and community services for the purpose of preventing and controlling obesity, as well as related chronic diseases, such as type 2 diabetes.

September 18th 2015

Stumbling Toward Access to Evidence-Based Care for the Chronic Disease of Obesity

Theodore K. Kyle, RPh, MBA Fatima Cody Stanford, MD, MPH, MPA

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door to improved coverage for pharmcotherapy. That did not happen right away, but signs of change are emerging.

September 18th 2015

Joslin's Hamdy: Evidence Shows Diet, Exercise Effective Against Diabetes, Obesity Long-Term

A 5-year study reveals that the properly constructed diet, along with exercise aimed at muscle maintenance, can achieve long-term weight loss results.

September 18th 2015

"Artificial Pancreas" System Performs Well in Home-Based Trial, Researchers Report

Mary K. Caffrey

Patients whose blood sugar and insulin delivery was managed by software had been control than those who had to self-monitor their insulin delivery.

September 18th 2015

NIH Approves Blueprint for Obama's Precision Medicine Initiative

Surabhi Dangi-Garimella, PhD

The path to President Obama's Precision Medicine Initiative has been paved as is evident from a report released by a Working Group convened by the National Institutes of Health.

September 18th 2015

Explaining a Mystery of Insulin-Producing Cells to Find Treatments for Type 2 Diabetes

Work at the Karolinska Institutet has revealed a potential new therapeutic target in type 2 diabetes.

September 17th 2015

Lancet Study Evaluates Cost-Effectiveness of Bariatric Surgery

Mary K. Caffrey

The long-term claimed to be the first to use real world data to capture the complete picture of the value of paying for bariatric surgery in patients with diabetes.

September 17th 2015

Empagliflozin Shown to Cut Mortality Risk in Long-Term CV Outcomes Trial

Mary K. Caffrey

Presentation of results at the European Association for the Study of Diabetes follows the announcement of topline results in August. For years, researchers and pharmaceutical leaders alike wondered if a diabetes therapy would be shown to have a cardioprotective effect.

September 16th 2015

What "Behavioral Change" Looks Like From the Front Lines: Visiting Jefferson Hospital

Mary K. Caffrey

Evidence-Based Diabetes Management gained exclusive access to the Comprehensive Weight Management Program for a view of what "behavioral change" really means for patients overcoming obesity and for the clinicians managing their care.

September 16th 2015

Omada Health Raises $48M for Obesity Prevention; Humana and Providence Among Investors

Mary K. Caffrey

The company's Prevent program is approved by CDC as meeting standards for obesity prevention counseling as required of payers by the US Prevention Services Task Force.

September 15th 2015

Do Patient or Provider Characteristics Impact Management of Diabetes?

Erin S. LeBlanc, MD, MPH A. Gabriela Rosales, MS Sumesh Kachroo, PhD Jayanti Mukherjee, PhD Kristine L. Funk, MS Gregory A. Nichols, PhD

Many more patient than provider characteristics are associated with optimal or poor glycemic control and treatment intensification when glycemic control is initially lost.

September 15th 2015

Diabetes Care Study Finds Increased Cancer Risk With Glyburide

Researchers analyzed patient records from a 25-year period and found risks increased with higher doses and longer periods of treatment.

September 14th 2015

Sanofi Reports LixiLan-L Topline Results; Says Combo Superior to Insulin Alone

Mary K. Caffrey

Regulatory filings with the FDA are expected before the end of the year.

September 13th 2015

Insurance Increases Diagnosis and Control of Chronic Conditions

Laura Joszt, MA

People with insurance have significantly higher probabilities of being diagnosed for diabetes, hypercholesterolemia, and hypertension than people without insurance.

September 11th 2015

Understanding Antipsychotic Drug Mechanisms Helps Predict Side Effects-and How to Respond

Mary K. Caffrey

Peter Weiden, MD, says that psychiatrists have greater ability to address side effects from antipsychotics than they did 10 years ago. It's essential that clinicians take patient concerns seriously, because when they don't patients may react by stopping their medication.

September 10th 2015

New Jersey's Horizon Alliance Breaks New Ground in Payment Reform

Mary K. Caffrey

As CMS pushes healthcare systems to move away from fee-for-service, the state's largest insurer makes a major move toward value-based payment.

September 9th 2015

Surgeon General Urges Americans to Walk More to Combat Chronic Disease

Mary K. Caffrey

Research shows that about 150 minutes per week of moderate exercise, such as walking, can have significant health benefits. Changes in American lifestyles in recent decades have made limited the amount of time spent walking, with unfortunate results.

September 8th 2015

Vitamin C May Help Overweight Patients Who Won't Exercise

Mary K. Caffrey

Exercise is still recommended for those who are overweight, but the study suggests a vitamin C supplement can help those patients who can't or won't pursue activity.

September 7th 2015

DPP-4 Inhibitors Subject of FDA Safety Warning

FDA has warned that the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling. In a statement, the FDA said said it had issued a "warning and precaution" to all labels in this drug class.

September 4th 2015

What Can Mouse Gut Bacteria Teach Us About Obesity?

Mary K. Caffrey

The experiments are revealing the relationship between bacteria in the digestive tract and a genetic disposition toward diabetes or obesity.

September 3rd 2015

Young at Heart? Most Americans Aren't, CDC Research Finds

Mary K. Caffrey

The difference between "heart age" and chronological age indicates risk of events like heart attacks and strokes, and could motivate younger patients to improve unhealthy lifestyles.

...

69 70 71 72 73 74 75 76 77

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions